PRQR:NASDAQ
ProQR Therapeutics NV
$1.83
arrow_downward
-3.17%(-0.060) 1D
$1.91
arrow_upward
+4.37% (+0.080)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRQR...
Open
$1.89
High
$1.89
Low
$1.83
Mkt. cap
258.25M
Avg. vol.
820.87K
Volume
570.09K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.45
Beta
0.06
Shares outstanding
138.09M
No. of employees
187
Open
$1.89
High
$1.89
Low
$1.83
Mkt. cap
258.25M
Avg. vol.
820.87K
Volume
570.09K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.45
Beta
0.06
Shares outstanding
138.09M
No. of employees
187
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
PRQR Q1 2026 Earnings: EPS Misses Estimates as Pipeline Progress Continues - Forward EPS Estimate
Profile
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
About ProQR Therapeutics NV